BSE filing, NSE: BANDHANBNK. Summary written from the filing by ALFA Finder's alert engine.
Bandhan Bank Ltd: key numbers
- Share price
- ₹154.33
- Market cap
- ₹24,865 Cr
- Revenue (annual)
- ₹21,689 Cr
- Net profit (annual)
- ₹1,224 Cr
- P/E (TTM)
- 13.3×Sector 19.8×
- Promoter holding
- 37.00%-0.54% QoQ
- FII holding
- 17.16%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bandhan Bank Ltd
All →Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Bandhan Bank Earnings Call Transcript: Key Takeaways
Bandhan Bank is pivoting from its MFI roots toward a universal banking model, with non-EEB growth and secured assets stabilizing the balance sheet despite CASA pressure and transitionary headwinds in housing.
- Call
- Guides 14% growth
Bandhan Bank Investor Presentation: Key Takeaways
Q2FY27: PAT ₹6.2bn (+23.9% QoQ), NII ₹29.6bn (+14.4% YoY), operating profit ₹15.6bn (+18.8% YoY), NIM 6.1%, GNPA 3.1%. Secured mix rose to 57.3%.
Bandhan Bank Q2 FY27 Results: Net Profit ₹621.8 Cr, Up 455.7% YoY
Bandhan Bank Ltd reported revenue from operations of ₹5,754 Cr (+7.5% YoY) and net profit of ₹621.8 Cr (+455.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹621.8 Cr · +455.7% YoY
Bandhan Bank Price Movement Clarification
Bandhan Bank denies a Moneycontrol report linking it to First Abu Dhabi Bank acquisition talks, stating the reference in the article is factually incorrect.
Bandhan Bank Other Announcement
Bandhan Bank Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required by regulatory compliance.
Other results update announcements
All →Medi Assist Healthcare Services Results Update
Medi Assist reported H1 FY27 results with higher revenue, EBITDA and profit year-on-year. It also announced a board-approved share buyback.
Neogen Chemicals Results Update
Neogen Chemicals issued its Q2 FY27 press release on unaudited results, showing higher year-on-year revenue and profit. Battery chemicals ramp-up and the QIP proceeds featured prominently.
Surani Steel Tubes Results Update
Surani Steel Tubes issued an earnings press release for H1 FY27, reporting revenue of Rs.290.86 Crore and PAT of Rs.5.94 Crore. The release states that both figures exceed the company's previous full-year records.
Shree Ganesh Remedies Results Update
Shree Ganesh Remedies released a press release on Q2 and H1 FY27 unaudited results, with Q2 revenue of ₹23.29 Crore, down 23% year-on-year. PAT fell 67% to ₹1.63 Crore.
Zen Technologies Results Update
Zen Technologies released its Q2 and H1 FY27 unaudited results, reporting consolidated Q2 revenue of ₹345.13 Crore, up 98.8% year-on-year. Order book stands at ₹1,375.70 Crore.
- Order book
- ₹1,376 Cr
Sai Parenterals Results Update
Sai Parenterals reported Q2FY27 consolidated revenue of Rs. 196 crore and PAT of Rs. 11 crore. Gross margin improved to 47.5%.